BioPharma

Meanwhile, after subtracting allowances such as rebates and discounts, net prices that health plans paid for medicines dropped by 1.4%, compared with a 1.8% decline in last year’s second quarter, according to SSR Health.

New report shows leading Covid-19 vaccine pharma companies fuelling unprecedented human rights crisis.

The CEO of Pfizer is asking his employees for help to make sure Congress does not pass a provision that allows Medicare to negotiate for cheaper drug costs.

At issue is whether the companies have to offer discount pricing to safety-net providers through certain contract pharmacy partnerships.

He added that the company would share methods to raise awareness on the issue in the next few days.

True or false: Pharmaceutical companies are required to send drug ads to the FDA for approval before they're used.

New reporting from The Intercept shows how Senator Joe Manchin's daughter, Heather Bresch, played a large role in Mylan's EpiPen price-fixing scandal.

Listen in to hear healthcare research insights to drive pricing and market access strategies for the pharma sector.

The Sacklers contributed approximately $4.5 billion to the plan, which had wide support from creditors who voted on it, but critics have been angered that the family will retain billion of dollars and never face a public civil trial.

While Congress and the U.S. government have sought to lower drug prices for years, the issue appears to be coming to a head once again in Washington, D.C.

The U.S. Justice Department sued Teva in August 2020. It alleged that the company illegally paid two purportedly independent charitable foundations $328 million from 2006 to 2015.

The fight against Covid-19 is further fueling the greed of pharmaceutical companies. Does the industry’s influence threaten public health systems?

Investigative reporters Stephen Janis and Taya Graham explain why Big Pharma is lobbying against allowing the federal government to negotiate drug prices.

Bausch has agreed to pay $300 million to settle an antitrust lawsuit accusing it of illegally maintaining a monopoly on the diabetes drug Glumetza, enabling a nearly 800% price hike in 2015.

As Congress reconvenes this month to resolve a $3.5 trillion budget package, Democrats are focused on enacting sweeping legislation that would allow the government to negotiate prices for prescription drugs.